St. Jude Medical, FDA And Top Pediatric Cardiology Experts Announce New Clinical Trial To Treat Congenital Heart Defects

News The patients who would be eligible for this study are the tiniest and most fragile we care for--severely premature newborns who in many cases are critically ill from the presence of a patent ductus arteriosus. Contributed Author:  Business Wire Topics:  Surgical